surmount-1 tirzepatide weight loss results Body composition changes during reduction with in the SURMOUNT‐1 study of adults with obesity or overweight - Look - 2025 - Diabetes, Obesity and Metabolism SURMOUNT-1: Tirzepatide results in 22.5%

Functional medicine has evolved integrative, holistic, conventional and naturopathic models to offer the most comprehensive and effective approach to healthcare in the 21st century

TB-500 Although BPC-157 and TB-500 are often grouped together, they are not the same peptide

Tirzepatide is administered as a once-weekly injection, which can be done at home or during an office visit

It means your fueling strategy should support the work you are asking your body to do

Understanding your genetic peptide-pathway profile can support a more informed conversation with your gastroenterologist about whether GLP-1 warrants a cautious trial, what starting dose and monitoring schedule makes sense, and how to distinguish medication side effects from disease flares

While tirzepatide is highly effective as monotherapy, combining pharmacological treatment with evidence-based lifestyle modifications significantly enhances outcomes and supports long-term weight maintenance